All Nicotine Products Damage The Heart, Major Scientific Review Concludes

The method of delivery is irrelevant: Nicotine itself is bad news for blood vessels.

The vape in your pocket, the nicotine pouch under your lip, the heated tobacco device marketed as “reduced risk”— none of them are safe for your heart. That’s the main takeaway from a major scientific consensus, which systematically dismantles the idea that alternative nicotine products protect cardiovascular health.

For the first time, leading heart experts from Europe and the United States have issued a unified declaration: nicotine itself, regardless of how it’s delivered, directly damages blood vessels and increases cardiovascular risk. The policy statement, published in the European Heart Journal, reviewed decades of evidence across all nicotine delivery systems, from traditional cigarettes to the newest synthetic nicotine pouches flooding convenience stores.

The authors write that no nicotine-containing product, whether smoked, heated, vaped, or absorbed through the mouth, can be considered safe for the heart and blood vessels. The one exception they note is medically supervised, time-limited nicotine replacement therapy (such as patches or gums) used specifically to quit smoking, where the benefits of quitting outweigh the risks. This position aligns with guidance from the European Society of Cardiology, American Heart Association, U.S. Food and Drug Administration, and World Health Organization.

While cigarette smoking has declined in many countries, alternative nicotine products have exploded in popularity, particularly among young people who might never have smoked otherwise. Between 2011 and 2019, e-cigarette use among U.S. high school students skyrocketed from 1.5% to 27.5%. European surveys found similar trends, with up to 40% of adolescents in some countries having tried e-cigarettes by age 16.

Every Nicotine Product Damages Blood Vessels

The tobacco industry has spent decades rebranding nicotine addiction. First came filtered cigarettes, then “light” cigarettes, then e-cigarettes marketed as harm reduction tools. Now synthetic nicotine pouches are sold with “tobacco-free” labels that mislead consumers into believing they’re safe.

But the scientific evidence tells a different story. The authors reviewed studies across every major nicotine delivery system and found consistent cardiovascular harm across the board.

E-cigarettes show particularly deceptive risks. Studies measuring flow-mediated dilation (a gold-standard test of blood vessel function) found e-cigarette users show impairment comparable to cigarette smokers. While e-cigarettes emit fewer carcinogens than combusted tobacco, they still expose users to high nicotine doses plus aldehydes, fine particles, and metal nanoparticles from heating coils. Animal studies show e-cigarette aerosol causes oxidative stress and damages the vessel lining even without combustion products.

Heated tobacco devices like IQOS heat rather than burn tobacco, reducing some combustion byproducts. Yet research demonstrates they still impair blood vessel function and increase cellular damage. Switching from cigarettes to heated tobacco products leads to partial vascular recovery, but not normalization. Children exposed to secondhand aerosol from these devices showed vascular damage comparable to traditional secondhand smoke.

Waterpipes, often perceived as less harmful due to water “filtration,” deliver massive smoke volumes. A single 45-minute waterpipe session produces as much smoke as 100 cigarettes, containing carbon monoxide, heavy metals, and carcinogens. Chronic waterpipe users show impaired blood vessel function, increased arterial stiffness, and higher systemic inflammation.

Smokeless nicotine products like pouches, lozenges, and snus deliver nicotine through oral absorption. Despite eliminating inhaled toxicants, they still damage the vessel lining, activate stress responses, and increase blood pressure. Swedish studies linked snus use to higher cardiovascular and all-cause mortality, particularly in individuals with prior heart attacks or strokes.

Even cigars pose serious risks. A study of over 103,000 adults found cigar use associated with increased stroke and heart disease risk, even among those who don’t inhale deeply.

How Nicotine Attacks the Cardiovascular System

The consistency of harm across products points to nicotine itself as the culprit. When absorbed into the bloodstream, nicotine binds to specific receptors throughout the nervous system, triggering cardiovascular stress.

Nicotine activates the “fight or flight” response, stimulating release of stress hormones like adrenaline. This causes immediate increases in heart rate, blood pressure, and the force of heart contractions. With chronic exposure, sustained activation promotes hypertension, abnormal heart rhythms, and changes in heart structure.

The damage extends to the endothelium (the delicate inner lining of blood vessels). This layer regulates blood flow, prevents clots, and controls inflammation. Nicotine impairs these protective functions, making vessels less able to relax and respond properly to the body’s demands.

At the molecular level, nicotine disrupts the production of nitric oxide, a molecule that keeps blood vessels healthy. Instead of producing this protective compound, the affected enzyme generates harmful molecules that amplify damage.

The consequences accumulate. Nicotine increases arterial stiffness, making the heart work harder. It boosts blood clotting while constricting coronary arteries—particularly dangerous in people with pre-existing narrowed arteries. Animal studies show nicotine promotes heart scarring and enlargement, reducing pumping efficiency.

‘Harm Reduction’ Products Still Cause Harm

The marketing narrative of “safer nicotine” has failed to deliver. E-cigarettes were promoted as tools to help smokers quit, yet real-world evidence shows they’ve primarily created new addicts and sustained dual use.

Most e-cigarette users don’t fully switch from cigarettes. Dual use (continuing to smoke while also vaping) is the dominant pattern, especially among 18-35 year-olds. This undermines any theoretical harm reduction.

A recent study of over 33,000 patients after heart procedures found that only those who completely stopped smoking and vaping showed reductions in heart attacks and death. Dual users fared no better than continued smokers. Those who switched exclusively to e-cigarettes experienced modest risk reduction, but still faced substantially higher cardiovascular risk than complete quitters.

The evidence for e-cigarettes as effective cessation tools remains weak. About 10-18% of smokers quit successfully using e-cigarettes versus 9% with nicotine replacement therapy—a modest difference. Most who quit using e-cigarettes continued vaping at 12 months, indicating persistent dependence rather than true cessation.

The World Health Organization does not recommend e-cigarettes as a cessation tool in its 2024 clinical guidelines, citing insufficient long-term safety data. The European Society of Cardiology and American Heart Association suggest e-cigarettes should be considered only as a last resort within structured cessation programs, not as over-the-counter consumer products.

How Nicotine Products Target Vulnerable Teen Brains

Modern nicotine products specifically target adolescents whose developing brains are uniquely susceptible to addiction. Nicotine exposure during adolescence alters brain chemistry in ways that boost reward sensitivity and prime the brain for other substance use.

The industry exploits this through design and marketing. Modern pod-based systems use nicotine salts to deliver high doses rapidly with minimal throat irritation. A single JUUL pod contains nicotine equivalent to 20 cigarettes.

Flavored products like cotton candy, mango, and mint are aggressively promoted through social media influencers. Three-quarters of young adult e-cigarette users aged 18-20 have never smoked traditional cigarettes, meaning these products are recruiting new addicts. In the UK, youth vaping grew 50% between 2022 and 2023. The British Medical Association has called this a “public health emergency.”

Secondhand Exposure Carries Real Risks

The harms extend beyond users to innocent bystanders. Over 1.2 million deaths annually worldwide are attributable to secondhand tobacco smoke. Non-smokers living with smokers face 30% higher risk of coronary artery disease, and exposure as brief as 30 minutes acutely impairs blood vessel function.

E-cigarette aerosols are not “just water vapor.” Exhaled vapor introduces nicotine, propylene glycol, aldehydes, metals, and ultrafine liquid particles into ambient air. Research shows non-smokers exposed to e-cigarette aerosol experienced impaired blood vessel function and elevated inflammation markers, with one study finding effects comparable to passive cigarette smoke.

Waterpipe sessions produce dense smoke clouds, with passive exposure sometimes exceeding that of cigarettes. Even heated tobacco products expose bystanders to nicotine and volatile compounds that impair vascular function in children and young adults.

The authors call for broad indoor and outdoor bans on smoking, vaping, and waterpipes, particularly near playgrounds, schools, outdoor restaurant seating, public transport stops, hospital grounds, and parks.

The research makes clear that decades of evidence confirm all nicotine products pose serious cardiovascular risks. The only truly safe level of nicotine use for cardiovascular health is zero. Policymakers face an urgent task: implement unified regulation ending the illusion of “safer” alternatives and protecting current and future generations from nicotine’s cardiovascular harms.

---

Disclaimer: This article is based on a scientific policy statement published in the European Heart Journal and is intended for informational purposes only. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. If you use nicotine products and want to quit, consult with a healthcare provider about evidence-based cessation methods. The exception noted for medically supervised nicotine replacement therapy refers to short-term use under medical guidance specifically for smoking cessation, not chronic recreational use.

---